0001179110-20-004928.txt : 20200417 0001179110-20-004928.hdr.sgml : 20200417 20200417160308 ACCESSION NUMBER: 0001179110-20-004928 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170416 FILED AS OF DATE: 20200417 DATE AS OF CHANGE: 20200417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cappucci Gabriel R. CENTRAL INDEX KEY: 0001417243 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 20799688 MAIL ADDRESS: STREET 1: 100 PARSONS POND DRIVE CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2017-04-16 0 0001477449 Teladoc Health, Inc. TDOC 0001417243 Cappucci Gabriel R. C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Senior VP, Controller and CAO Common Stock 2020-04-16 4 M 0 2734 9.60 A 6077 D Common Stock 2020-04-16 4 M 0 2355 12.21 A 8432 D Common Stock 2020-04-16 4 M 0 14850 22.30 A 23282 D Common Stock 2020-04-16 4 S 0 19939 169.16 D 3343 D Common Stock 2020-04-16 4 S 0 2355 165.93 D 988 D Employee Stock Option (right to buy) 9.60 2020-04-16 4 M 0 2734 0.00 D 2025-04-22 Common Stock 2734 0 D Employee Stock Option (right to buy) 12.21 2020-04-16 4 M 0 2355 0.00 D 2026-03-07 Common Stock 2355 0 D Employee Stock Option (right to buy) 22.30 2020-04-16 4 M 0 14850 0.00 D 2027-03-03 Common Stock 14850 4950 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 2, 2020. Represents the weighted average price of transactions ranging from $166.05 to $171.55. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. The option vested as to 25% of the shares on April 22, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter. The option vested as to 25% of the shares on March 7, 2017. The remainder of the shares vested in 36 equal monthly installments thereafter. The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. /s/ Adam C. Vandervoort, attorney-in-fact 2020-04-17